Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - TITAN PHARMACEUTICALS INC | tm211758d1_ex32-1.htm |
| EX-31.1 - EXHIBIT 31.1 - TITAN PHARMACEUTICALS INC | tm211758d1_ex31-1.htm |
| 10-K - FORM 10-K - TITAN PHARMACEUTICALS INC | tm211758d1_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-1 (File Nos. 333- 226841, 333-233722, 333-251187 and 333-252482), Form S-8 (File Nos. 333-171181 and 333-207950) and Form S-3 (File Nos. 333-230742 and 333-221126) of our report dated March 31, 2021 (which report expresses an unqualified opinion and includes an explanatory paragraph expressing substantial doubt about the Company’s ability to continue as a going concern) relating to the financial statements of Titan Pharmaceuticals, Inc., which appears in this Annual Report on Form 10-K.
| /s/ OUM & CO. LLP | |
| San Francisco, California | |
| March 31, 2021 |
66